Prognostic Value of Coronary Dominance in Patients Undergoing Elective Coronary Artery Bypass Surgery
AUTOR(ES)
Selcuk, Emre
FONTE
Braz. J. Cardiovasc. Surg.
DATA DE PUBLICAÇÃO
13/01/2020
RESUMO
Abstract Objective: To evaluate the clinical impact of coronary dominance type in terms of early and long-term outcomes in patients undergoing elective coronary artery bypass grafting (CABG). Methods: A total of 844 consecutive patients who underwent elective CABG were divided into two groups based on preoperative angiographic views as left dominant (LD) and right dominant or co-dominant (RD+CD). The measured outcomes were postoperative complications, 30-day mortality, long-term mortality, and major adverse cardiac and cerebrovascular events (MACCE). Results: RD+CD was present in 87.9% (n=742) and LD in 12.1% (n=102) of patients. Postoperative complications, 30-day mortality, and 30-day readmissions were similar in both groups. The median duration of follow-up was 3.4 years. LD was not an independent predictor of mortality (adjusted hazard ratio [HR] 1.53, 95% confidence interval [CI] 0.89-2.45, P=0.12), but it was an independent predictor of MACCE in the long term (adjusted HR 2.18, 95% CI 1.39-3.42, P=0.001). Conclusion: In patients undergoing elective surgical revascularization, left coronary dominance is associated with increased MACCE risk in the long term. Therefore, the assessment of coronary dominance type should be an integral part of outpatient management after CABG.
Documentos Relacionados
- Prognostic Value of Coronary Dominance in Patients Undergoing Elective Coronary Artery Bypass Surgery
- Are Coronary Angiograms of Value in the Risk Stratification of Patients Undergoing Coronary Artery Bypass Surgery?
- Predictive Value of QT Interval for Postoperative Atrial Fibrillation in Patients Undergoing Off-Pump Coronary Artery Bypass Surgery
- Prognosis and Complications of Diabetic Patients Undergoing Isolated Coronary Artery Bypass Surgery
- Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery.